Dogwood Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -7,572 | -2,301 | -1,069 | -1,314 |
Net Income | -7,727 | -2,280 | -1,049 | -1,291 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,131 | -910 | -811 | -937 |
Cash | 14,847 | 2,039 | 3,020 | 2,379 |
Basic Shares | 1,310 | 1,110 | 916 | 770 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -12,245 | -5,446 | -12,315 | -15,640 |
EBIT | -12,258 | |||
Net Income | -12,349 | -5,296 | -12,247 | -15,960 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,790 | -4,870 | -11,467 | -15,689 |
Cash | 14,847 | 3,316 | 7,030 | 14,008 |
Basic Shares | 1,310 | 751 | 442 | 333 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$6.28 |
2024-09-30 | -$2.05 |
2024-06-30 | -$1.25 |
2024-03-31 | -$1.75 |
